ES554144A0 - Procedimiento de obtencion de un material laminar para el suministro transdermico continuo de nitroglicerina a un paciente. - Google Patents

Procedimiento de obtencion de un material laminar para el suministro transdermico continuo de nitroglicerina a un paciente.

Info

Publication number
ES554144A0
ES554144A0 ES554144A ES554144A ES554144A0 ES 554144 A0 ES554144 A0 ES 554144A0 ES 554144 A ES554144 A ES 554144A ES 554144 A ES554144 A ES 554144A ES 554144 A0 ES554144 A0 ES 554144A0
Authority
ES
Spain
Prior art keywords
sensitive adhesive
pressure
transdermic
nitroglycerine
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES554144A
Other languages
English (en)
Other versions
ES8802370A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Riker Laboratories Inc
Original Assignee
Riker Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riker Laboratories Inc filed Critical Riker Laboratories Inc
Publication of ES554144A0 publication Critical patent/ES554144A0/es
Publication of ES8802370A1 publication Critical patent/ES8802370A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ES554144A 1985-04-19 1986-04-18 Procedimiento de obtencion de un material laminar para el suministro transdermico continuo de nitroglicerina a un paciente. Expired ES8802370A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/725,215 US4751087A (en) 1985-04-19 1985-04-19 Transdermal nitroglycerin delivery system

Publications (2)

Publication Number Publication Date
ES554144A0 true ES554144A0 (es) 1988-05-16
ES8802370A1 ES8802370A1 (es) 1988-05-16

Family

ID=24913627

Family Applications (1)

Application Number Title Priority Date Filing Date
ES554144A Expired ES8802370A1 (es) 1985-04-19 1986-04-18 Procedimiento de obtencion de un material laminar para el suministro transdermico continuo de nitroglicerina a un paciente.

Country Status (14)

Country Link
US (1) US4751087A (es)
EP (1) EP0219539B1 (es)
JP (1) JP2588180B2 (es)
AT (1) ATE76736T1 (es)
AU (1) AU593810B2 (es)
CA (1) CA1273871A (es)
CZ (1) CZ390591A3 (es)
DE (1) DE3685545T2 (es)
ES (1) ES8802370A1 (es)
IE (1) IE59725B1 (es)
IL (1) IL78527A (es)
NZ (1) NZ215746A (es)
WO (1) WO1986006281A1 (es)
ZA (1) ZA862945B (es)

Families Citing this family (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5422118A (en) * 1986-11-07 1995-06-06 Pure Pac, Inc. Transdermal administration of amines with minimal irritation and high transdermal flux rate
US4746515A (en) * 1987-02-26 1988-05-24 Alza Corporation Skin permeation enhancer compositions using glycerol monolaurate
JPH0696529B2 (ja) * 1987-03-31 1994-11-30 積水化学工業株式会社 ニトログリセリン貼付剤およびその製造方法
US4906475A (en) 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
US5223261A (en) * 1988-02-26 1993-06-29 Riker Laboratories, Inc. Transdermal estradiol delivery system
JP2931002B2 (ja) * 1988-02-26 1999-08-09 ライカー ラボラトリース インコーポレーテッド 皮膚透過エストラジオールデリバリーシステム
US5719197A (en) * 1988-03-04 1998-02-17 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US4994278A (en) * 1988-03-04 1991-02-19 Noven Pharmaceuticals, Inc. Breathable backing
US5300291A (en) * 1988-03-04 1994-04-05 Noven Pharmaceuticals, Inc. Method and device for the release of drugs to the skin
DE3823070A1 (de) * 1988-07-07 1990-02-22 Kettelhack Riker Pharma Gmbh Selbstklebendes heftpflaster
EP0364211B1 (en) * 1988-10-11 1994-12-21 Shire Holdings Ltd. A percutaneous pharmaceutical preparation
US5008110A (en) * 1988-11-10 1991-04-16 The Procter & Gamble Company Storage-stable transdermal patch
US5238944A (en) * 1988-12-15 1993-08-24 Riker Laboratories, Inc. Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine
US5736553A (en) * 1988-12-15 1998-04-07 Riker Laboratories, Inc. Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo 4,5-C!quinolin-4-amine
US5332577A (en) * 1988-12-27 1994-07-26 Dermamed Transdermal administration to humans and animals
US5241925A (en) * 1988-12-27 1993-09-07 Dermamed Apparatus and techniques for administering veterinary medicaments
US5091186A (en) * 1989-08-15 1992-02-25 Cygnus Therapeutic Systems Biphasic transdermal drug delivery device
US5262165A (en) * 1992-02-04 1993-11-16 Schering Corporation Transdermal nitroglycerin patch with penetration enhancers
US5324521A (en) * 1989-12-18 1994-06-28 Dermamed Systems for transdermal administration of medicaments
EP0436203B1 (en) * 1989-12-28 1996-04-03 Nitto Denko Corporation Percutaneous gel preparation
US5204109A (en) * 1989-12-28 1993-04-20 Nitto Denko Corporation Percutaneous gel preparation
US5057500A (en) * 1990-02-12 1991-10-15 Dermatologic Research Corporation Treatment of pruritis with esters and amides
JP2820306B2 (ja) * 1990-02-27 1998-11-05 積水化学工業株式会社 経皮吸収製剤
JPH07116032B2 (ja) * 1990-04-06 1995-12-13 積水化学工業株式会社 ニトログリセリン貼付剤
CA2039586A1 (en) * 1990-05-02 1991-11-03 Marian R. Appelt Crosslinked pressure-sensitive adhesives tolerant of alcohol-based excipients used in transdermal delivery devices and method of preparing same
GB9021674D0 (en) * 1990-10-05 1990-11-21 Ethical Pharma Ltd Transdermal device
US5122383A (en) * 1991-05-17 1992-06-16 Theratech, Inc. Sorbitan esters as skin permeation enhancers
US5202125A (en) * 1990-12-10 1993-04-13 Theratech, Inc. Method and systems for administering nitroglycerin transdermally at enhanced transdermal fluxes
WO1992022292A1 (de) 1991-06-10 1992-12-23 Schwarz Pharma Ag Nitroglycerin-pflaster und verfahren zu seiner herstellung
US5273755A (en) * 1991-08-23 1993-12-28 Cygnus Therapeutic Systems Transdermal drug delivery device using a polymer-filled microporous membrane to achieve delayed onset
US5273756A (en) * 1991-08-23 1993-12-28 Cygnus Therapeutic Systems Transdermal drug delivery device using a membrane-protected microporous membrane to achieve delayed onset
US5234690A (en) * 1991-08-23 1993-08-10 Cygnus Therapeutic Systems Transdermal drug delivery device using an unfilled microporous membrane to achieve delayed onset
US5278192A (en) * 1992-07-02 1994-01-11 The Research Foundation Of State University Of New York Method of vasodilator therapy for treating a patient with a condition
GB2273044B (en) * 1992-12-02 1997-04-09 Pacific Chem Co Ltd Medicinal patches for percutaneous administration
US5762952A (en) * 1993-04-27 1998-06-09 Hercon Laboratories Corporation Transdermal delivery of active drugs
JP2539330B2 (ja) * 1993-05-11 1996-10-02 日東電工株式会社 医療用粘着剤及びこれを用いて形成された医療用外用材
WO1995001767A1 (en) * 1993-07-08 1995-01-19 Cygnus Therapeutic Systems Monolithic matrix transdermal delivery system
US5385736A (en) * 1993-07-12 1995-01-31 Minnesota Mining And Manufacturing Company Transdermal melatonin delivery system
US5494680A (en) * 1993-12-08 1996-02-27 Minnesota Mining And Manufacturing Company Transdermal delivery device
GB2292520B (en) * 1994-08-25 1998-09-02 Univ Sheffield Transdermal dressings for animals
CA2198390C (en) * 1994-09-14 2009-08-11 James E. Garbe Matrix for transdermal drug delivery
JP3604177B2 (ja) * 1994-09-14 2004-12-22 日東電工株式会社 経皮吸収製剤
US5702720A (en) * 1995-12-22 1997-12-30 Minnesota Mining And Manufacturing Company Transdermal device for the delivery of flurbiprofen
AU732803B2 (en) * 1996-01-17 2001-05-03 National Starch And Chemical Investment Holding Corporation Adhesives resistant to skin-penetration enhancers
JP3628809B2 (ja) * 1996-06-10 2005-03-16 アルケア株式会社 薬剤徐放性医療用配合物及びその製造方法
EP0998274B1 (en) 1997-06-23 2006-01-18 Cellegy Pharmaceuticals, Inc Microdose therapy of vascular conditions by no donors
US20040018241A1 (en) * 1997-09-26 2004-01-29 Noven Pharmaceuticals, Inc. Bioadhesive compositions and methods for topical administration of active agents
EP1021204B1 (en) 1997-09-26 2005-12-28 Noven Pharmaceuticals, Inc. Bioadhesive compositions and methods for topical administration of active agents
AU1728099A (en) * 1997-12-22 1999-07-12 Alza Corporation Monoglyceride and ethyl palmitate permeation enhancer compositions
DE19818955C2 (de) * 1998-04-28 2000-06-29 Lohmann Therapie Syst Lts Zusammensetzung, enthaltend Polyacrylat, Polyterpen, Nitroglycerin und wahlweise Polyvinylacetat
DE19830648A1 (de) * 1998-07-09 2000-01-13 Lohmann Therapie Syst Lts Glyceroltrinitrathaltige Zusammensetzung, Verfahren zu ihrer Herstellung und ihre Verwendung
US6160086A (en) * 1998-07-30 2000-12-12 3M Innovative Properties Company Process for removing impurities from polymers
JP2002523144A (ja) 1998-08-20 2002-07-30 スリーエム イノベイティブ プロパティズ カンパニー 包帯への噴霧および薬物送達システム
US6383511B1 (en) * 1999-10-25 2002-05-07 Epicept Corporation Local prevention or amelioration of pain from surgically closed wounds
US20020086065A1 (en) * 2000-10-31 2002-07-04 Katz David P. Methods and compositions for the benefit of those suffering from polycystic ovary syndrome with chromium complexes
US6682757B1 (en) 2000-11-16 2004-01-27 Euro-Celtique, S.A. Titratable dosage transdermal delivery system
US6638981B2 (en) * 2001-08-17 2003-10-28 Epicept Corporation Topical compositions and methods for treating pain
CN1653059A (zh) 2002-03-08 2005-08-10 卫材株式会社 用作医药品的大环化合物
IL166687A0 (en) 2002-08-30 2006-01-15 Alza Corp Embossable and writable multilaminate backing construction
KR101080026B1 (ko) * 2003-06-24 2011-11-04 니프로 패치 가부시키가이샤 의료용 경피 흡수 테이프 제제용 비수성 점착제 및 의료용경피 흡수 테이프 제제 및 그 제조법
DE10340428B4 (de) 2003-09-02 2015-02-12 Acino Ag Opioides Analgetikum enthaltende transdermale Formulierung
US20050065062A1 (en) * 2003-09-24 2005-03-24 3M Innovative Properties Company Method of formulating a pharmaceutical composition
JP4881006B2 (ja) * 2004-01-20 2012-02-22 ニプロパッチ株式会社 ツロブテロール貼付剤
ES2650188T3 (es) * 2004-06-10 2018-01-17 3M Innovative Properties Company Dispositivo y kit de aplicación de parches
US20060029654A1 (en) * 2004-08-04 2006-02-09 Cassel R D Analgesic patch for sports injury rehabilitation medicine and method to alleviate pain
US8039528B2 (en) * 2004-10-19 2011-10-18 3M Innovative Properties Company Method for the manufacture of pressure sensitive adhesives
CA2588943C (en) 2004-12-15 2013-02-26 Saitama Daiichi Pharmaceutical Co., Ltd. Medical tape preparation
US8080560B2 (en) * 2004-12-17 2011-12-20 3M Innovative Properties Company Immune response modifier formulations containing oleic acid and methods
US20060223786A1 (en) * 2005-04-01 2006-10-05 Smith David J Transdermal pain control method and device
GT200600396A (es) * 2005-09-07 2007-04-23 Dispositivos para la aplicacion de medicamentos transdermicos conteniendo o-desmetil venlafaxina (odv) o sus sales
US8889154B2 (en) 2005-09-15 2014-11-18 Medicis Pharmaceutical Corporation Packaging for 1-(2-methylpropyl)-1H-imidazo[4,5-c] quinolin-4-amine-containing formulation
US20070259026A1 (en) * 2006-04-20 2007-11-08 Robert Ang Vasodialating dressing for use with intravenous catheters
US20070248657A1 (en) * 2006-04-25 2007-10-25 Smith David J Multi-compartment transdermal pain control device
AU2007275815A1 (en) * 2006-07-18 2008-01-24 Wirra Ip Pty. Ltd. Immune response modifier formulations
AU2007279376B2 (en) * 2006-07-31 2012-09-06 Wirra Ip Pty Ltd Immune response modifier compositions and methods
EP2115140B8 (en) 2007-01-31 2017-01-25 Chongxi Yu Positively charged water-soluble prodrugs of 1H-imidazo[4,5-c]quinolin-4-amines and related compounds with very high skin penetration rates
DE102007021549A1 (de) 2007-05-08 2008-11-13 Novosis Ag Transdermales therapeutisches System enthaltend mindestens zwei Opioide
US20090304776A1 (en) * 2008-06-06 2009-12-10 Totada Shantha Transmucosal delivery of therapeutic agents and methods of use thereof
US7883487B2 (en) * 2008-06-16 2011-02-08 Shantha Totada R Transdermal local anesthetic patch with injection port
US20100160368A1 (en) * 2008-08-18 2010-06-24 Gregory Jefferson J Methods of Treating Dermatological Disorders and Inducing Interferon Biosynthesis With Shorter Durations of Imiquimod Therapy
US20100221313A1 (en) * 2008-12-01 2010-09-02 Innovative Pharmaceuticals, Llc Transdermal reservoir patch
LT2378876T (lt) 2008-12-19 2019-04-25 Medicis Pharmaceutical Corporation Mažesnio stiprumo dozės imikvimodo kompozicijos ir trumpi dozavimo režimai, skirti aktininės keratozės gydymui
BR112012000797A2 (pt) 2009-07-13 2016-08-09 Medicis Pharmaceutical Corp formulações de imiquimode de intensidade de dosagem inferior e regimes curtos de dosagem para tratamento de verrugas genitais e perianais
ES2574032T3 (es) * 2009-09-07 2016-06-14 Nipro Patch Co., Ltd. Preparación absorbible por vía transdérmica
WO2011163617A1 (en) 2010-06-25 2011-12-29 Graceway Pharmaceuticals, Llc Combination therapy with cryosurgery and low dosage strength imiquimod to treat actinic keratosis
US9849270B2 (en) 2011-12-16 2017-12-26 3M Innovative Properties Company Foldable adhesive composite dressing
EP2793869B1 (en) 2011-12-21 2015-09-23 3M Innovative Properties Company Transdermal adhesive patch assembly with removable microneedle array and method of using same
CN104024358B (zh) 2011-12-21 2016-02-10 3M创新有限公司 具有叠置衬片的粘合贴剂组件和系统及其制备方法
US20140004204A1 (en) * 2012-06-29 2014-01-02 University Of South Florida Biocompatible polyacrylate compositions and methods of use
US9782574B2 (en) 2012-10-10 2017-10-10 3M Innovative Properties Company Force-controlled applicator for applying a microneedle device to skin
WO2014078545A1 (en) 2012-11-16 2014-05-22 3M Innovative Properties Company Force-controlled applicator for applying a microneedle device to skin
SG11201507885TA (en) 2013-03-22 2015-11-27 3M Innovative Properties Co Microneedle applicator comprising a counter assembly
ES2686362T3 (es) 2013-05-31 2018-10-17 3M Innovative Properties Company Aparato de inyección de microagujas que comprende una accionador inverso
EP3003458B1 (en) 2013-05-31 2019-12-04 3M Innovative Properties Company Microneedle injection apparatus comprising a dual cover
EP3003457B8 (en) 2013-05-31 2021-02-24 Kindeva Drug Delivery L.P. Microneedle injection and infusion apparatus
US9642895B2 (en) 2013-08-12 2017-05-09 3M Innovative Properties Company Peptides for enhancing transdermal delivery
EP3020398A1 (en) 2014-11-17 2016-05-18 Nitto Denko Corporation Compounds and formulations for reducing scarring
CN108601749A (zh) 2016-02-05 2018-09-28 3M创新有限公司 具有氟代硅氧烷剥离衬件的透皮药物递送体系
EP3287462A1 (en) 2016-08-25 2018-02-28 Nitto Denko Corporation Isosorbide derivatives to treat bacterial biofilms

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3742951A (en) * 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
DE2528516A1 (de) * 1974-07-05 1976-01-22 Sandoz Ag Neue galenische zubereitung
DE2920500A1 (de) * 1979-05-21 1980-11-27 Boehringer Sohn Ingelheim Pharmazeutische zubereitung in form eines polyacrylatfilmes
JPS5777617A (en) * 1980-10-20 1982-05-15 Nichiban Co Ltd Plaster for cardiac disease
JPS5843368B2 (ja) * 1980-10-30 1983-09-27 日東電工株式会社 消炎鎮痛貼付剤
JPS6059207B2 (ja) * 1981-03-13 1985-12-24 日東電工株式会社 複合製剤の製法
JPS58913A (ja) * 1981-06-26 1983-01-06 Nitto Electric Ind Co Ltd 局所系医薬製剤
US4542013A (en) * 1981-07-08 1985-09-17 Key Pharmaceuticals, Inc. Trinitroglycerol sustained release vehicles and preparation therefrom
US4585452A (en) * 1983-04-12 1986-04-29 Key Pharmaceuticals, Inc. Transdermal systemic dosage forms
JPS59199628A (ja) * 1983-04-25 1984-11-12 Sekisui Chem Co Ltd 貼付剤
US4588580B2 (en) * 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
JPS61502760A (ja) * 1984-07-24 1986-11-27 キイ・フア−マシユ−テイカルズ・インコ−ポレイテツド 粘着性経皮投与層

Also Published As

Publication number Publication date
DE3685545D1 (de) 1992-07-09
AU5772586A (en) 1986-11-18
JPS62502965A (ja) 1987-11-26
NZ215746A (en) 1989-08-29
WO1986006281A1 (en) 1986-11-06
IL78527A (en) 1991-07-18
DE3685545T2 (de) 1992-12-24
IE59725B1 (en) 1994-03-23
AU593810B2 (en) 1990-02-22
ATE76736T1 (de) 1992-06-15
JP2588180B2 (ja) 1997-03-05
CA1273871A (en) 1990-09-11
US4751087B1 (es) 1993-03-02
ES8802370A1 (es) 1988-05-16
CZ390591A3 (en) 1993-07-14
EP0219539B1 (en) 1992-06-03
US4751087A (en) 1988-06-14
ZA862945B (en) 1987-12-30
EP0219539A1 (en) 1987-04-29
IL78527A0 (en) 1986-08-31
IE861035L (en) 1986-10-19

Similar Documents

Publication Publication Date Title
ES554144A0 (es) Procedimiento de obtencion de un material laminar para el suministro transdermico continuo de nitroglicerina a un paciente.
ES2030026T3 (es) Sistema terapeutico transdermal, su aplicacion y procedimiento para su fabricacion.
NL970007I1 (nl) Transdermaal oestradiotoedieningssysteem.
DE68912443D1 (de) Unterbrochene Haftklebeoberfläche.
ATE42901T1 (de) Haftendes arzneimittelpraeparat fuer perkutane absorption.
ES2068897T3 (es) Una sustancia biocompatible, tromborresistente que comprende hirudina, sus analogos o fragmentos, y metodos para producir la misma.
PT87936A (pt) Transdermal therapeutic system and use thereof
DE59006461D1 (de) Therapeutisches System zur verzögerten und gesteuerten transdermalen oder transmucosalen Verabreichung von Wirkstoffen (II).
DE3584766D1 (de) Transdermales system fuer timolol.
SE8605383D0 (sv) Flerfaldigt indelade transdermala och dermala plaster
NO912466L (no) Plaster med hoeyt innhold av mykgjoerende stoffer.
NO895172D0 (no) Fremgangsmaate for fremstilling av et transdermalt terapeutisk system med phytostigmin som virkestoff.
EP0138551A3 (en) A system for the transdermal delivery of nitroglycerin
IL106512A (en) Plaster for the transdermal application of steroid hormones and process for the preparation thereof
NO173804C (no) Primaerforpakning for flatestabiliserte forbindingsmaterialer
PT92903A (pt) Sistema terapeutico superficial contendo uma substancia activa antineoplastica,particularmente 5-fluorouracilo
DK333586A (da) Folie med kombineret forseglings- og oplaesningsbelaegning
NO895173L (no) Fremgangsmaate for fremstilling av et transdermalt terapeutisk system med norpseudoefedrin som virkestoff.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20100623